Bloodstream Infection Results in Hours

Early results support further clinical validation of a direct-from-blood diagnostic workflow

September 25, 2026
3 min

The Pathologist

Overview

A novel single-cell analysis platform enables rapid identification of bloodstream pathogens and their antimicrobial susceptibility within hours. The system demonstrated high concordance with clinical laboratory results, achieving identification in as little as 1.2 hours and susceptibility testing with 98% essential agreement, based on a study published in Science Advances.

Background

Bloodstream infections (BSIs) pose significant clinical challenges due to their high mortality rates and the increasing prevalence of antibiotic-resistant bacteria. Rapid identification and susceptibility testing are critical for timely and effective treatment, which can improve patient outcomes. Traditional methods often take 24 to 48 hours, highlighting the need for faster diagnostic technologies. Specific statistics on mortality rates and antibiotic resistance should be included to support these claims.

Data Highlights

Parameter	Result
Identification Time for K pneumoniae	6.75 hours
Identification Time for S aureus	14 hours
Concordance with Clinical Lab Identification	96%
Essential Agreement for AST	98%
Very Major Error Rate	4%
Minor Error Rate	2%

Key Findings

The single-cell analysis platform produced results in 6.75 to 17 hours for bloodstream pathogens, with specific identification times of 6.75 hours for K pneumoniae and 14 hours for S aureus at 1 CFU/mL.
Identification was concordant with clinical laboratory results in 96% of tested samples.
Antimicrobial susceptibility testing achieved 98% essential agreement with clinical results.
The workflow was tested using whole blood spiked with clinical bacterial isolates.

Clinical Implications

The rapid identification and susceptibility testing capabilities of this platform may facilitate timely treatment decisions in patients with bloodstream infections, as stated in the study. Further validation in clinical settings is necessary to confirm its efficacy and reliability.

Conclusion

This study presents advancements in the rapid diagnosis of bloodstream infections, with findings that require further validation in real-world clinical scenarios.